Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Melanoma × Endoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Barrett Esophagus 12 Esophageal Neoplasms 9 Colorectal Neoplasms 8 Stomach Neoplasms 6 Rectal Neoplasms 6 Nasopharyngeal Carcinoma 6 Colonic Neoplasms 5 Adenocarcinoma Of Esophagus 5 Gastroesophageal Reflux 4 Squamous Cell Carcinoma of Head and Neck 3 Pathologic Complete Response 3 Neoplasms 3 Carcinoma 3 Lung Neoplasms 2 Fistula 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Carcinoma, Non-Small-Cell Lung 2 Urogenital Neoplasms 1 Upper Tract Urothelial Carcinoma 1 Thyroid Neoplasms 1 Stomach Ulcer 1 Stomach Diseases 1 Signs and Symptoms 1 Sarcoma 1 Recurrence 1 Precancerous Conditions 1 Polyposis, Gastric 1 Peptic Ulcer 1 Paranasal Sinus Neoplasms 1

Interventions

Nivolumab 145 Ipilimumab 137 pembrolizumab 122 Cyclophosphamide 78 Interleukin-2 69 aldesleukin 63 Temozolomide 46 trametinib 37 Radiosurgery 37 Vemurafenib 36 fludarabine 34 Biopsy 34 dabrafenib 33 Radiotherapy 33 Blood Specimen Collection 31 fludarabine phosphate 30 sargramostim 27 Bevacizumab 27 Introns 23 Dacarbazine 22 Magnetic Resonance Spectroscopy 20 CTLA-4 Antigen 20 encorafenib 19 cobimetinib 19 binimetinib 19 Paclitaxel 19 Granulocyte-Macrophage Colony-Stimulating Factor 19 Specimen Handling 18 Cisplatin 17 incomplete Freund's adjuvant 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04879654 2024-03-05

SNMM

Eye & ENT Hospital of Fudan University

Phase 2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡